Meet our KEYNOTE SPEAKER
Vivienne Ming
Vivienne Ming
Author of “Robot-Proof: When Machines Have All the Answers, Build Better People”, serial entrepreneur and unconventional innovator creating technologies that amplify human potential.
BIO
Dr. Vivienne Ming explores maximizing human capacity as a theoretical neuroscientist, delusional inventor, and demented author. Over her career she’s founded 7 startups, been chief scientist at 2 others, and founded The Human Trust, a philanthropic data trust and “mad science incubator” building a foundation model for human development.
She co-founded Possibility Sciences to advance scientific discovery via massive scale hybrid intelligence. She also develops AI tools for learning at home and in school, models of bias in hiring and promotion, and neurotechnologies for dementia, TBI, and postpartum depression.
In her free time, Vivienne designs AI systems to treat her son’s diabetes, predict manic episodes in bipolar sufferers, and reunite orphan refugees with extended family members. For relaxation, she writes science fiction and spends time with her wife and children.
Vivienne was named one of “10 Women to Watch in Tech” by Inc. Magazine and one of the BBC’s 100 Women in 2017. She is featured frequently for her research and inventions in The Financial Times, The Atlantic, Quartz Magazine and the New York Times.
She co-founded Possibility Sciences to advance scientific discovery via massive scale hybrid intelligence. She also develops AI tools for learning at home and in school, models of bias in hiring and promotion, and neurotechnologies for dementia, TBI, and postpartum depression.
In her free time, Vivienne designs AI systems to treat her son’s diabetes, predict manic episodes in bipolar sufferers, and reunite orphan refugees with extended family members. For relaxation, she writes science fiction and spends time with her wife and children.
Vivienne was named one of “10 Women to Watch in Tech” by Inc. Magazine and one of the BBC’s 100 Women in 2017. She is featured frequently for her research and inventions in The Financial Times, The Atlantic, Quartz Magazine and the New York Times.